Anti-Counterfeiting Measures and USP Standards

USP works continuously and supportively with all parties who wish to combat counterfeit medicines. This activity is conducted primarily by USP management through USP's national and international public health programs. USP's standards–setting activities are directed primarily to practitioners and patients, working in concert with pharmaceutical manufacturers, pharmaceutical distributors, compounding professionals, and conformity assessment bodies such as FDA.

At no time should overt anti–counterfeiting measures interrupt or otherwise distort or disturb labeling and other standards created by the Council of Experts that reflect usual and customary communications between providers and patients/consumers in achieving access to and appropriate use of good quality, safe, and, where appropriate, beneficial, food and drugs.

All requests for incorporation of anti–counterfeiting measures in USP's standards-setting activities should be referred to the Council of Experts Executive Committee for discussion and, as appropriate, action. Via management, USP will work to promote anti–counterfeiting activities in the USP and elsewhere consistent with its mission.